US Stock MarketDetailed Quotes

BDTX Black Diamond Therapeutics

Watchlist
  • 4.740
  • -0.300-5.95%
Close May 23 16:00 ET
  • 4.860
  • +0.120+2.53%
Post 16:17 ET
266.71MMarket Cap-2855P/E (TTM)

Black Diamond Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Black Diamond Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.35

+38.60%
Analyst Rating

Strong Buy

May 16, 2024

Black Diamond Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Black Diamond Therapeutics Earnings Reports

  • Black Diamond Therapeutics | 10-Q: Quarterly report

    May 9 19:17

  • Black Diamond Therapeutics | 10-K: Annual report

    Mar 12 19:22

  • Black Diamond Therapeutics: Q3 2023 Earnings Report

    Nov 6, 2023 20:14

  • Black Diamond Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 19:26

    • Read more

    Analysis

    Analyst Rating

    Updated: May 16, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg